Article
Human CD4+ cytolytic T lymphocyte responses to a human immunodeficiency virus type 1 gp160 subunit vaccine.
The Journal of infectious diseases - 1 Jul 1993
Stanhope P E, Clements M L, Siliciano R F
Abstract excerpt
The development of an effective vaccine against human immunodeficiency virus type 1 (HIV-1) may require immunization protocols that elicit cytolytic T lymphocytes (CTL) in addition to neutralizing antibodies. This report demonstrates that vaccination of 4 HIV-1-seronegative volunteers with a recombinant HIV-1 gp160 vaccine produced in mammalian cells elicited a CTL response in 3. The observed CTL activity was not...
Topics
- AIDS Vaccines
- CD4-Positive T-Lymphocytes
- Clone Cells
- Gene Products, env
- HIV Envelope Protein gp160
- HIV Infections
- HIV-1
- Humans
- Longitudinal Studies
- Phenotype
- Protein Precursors
